WE‐DE‐BRA‐03: Construction of An Ultrasound Guidance Platform for Image‐Guided Radiotherapy with the Intent to Treat Transitional Cell Carcinoma

摘要

Purpose: Ultrasound (US) is a noninvasive, nonradiographic imaging technique with high spatial and temporal resolution that can be used for localizing soft‐tissue structures and tumors in real‐time during radiotherapy (inter‐ and intra‐fraction). A detailed methodology integrating 3D‐US within RT is presented. This method is easier to adopt into current treatment protocol than current US based systems and reduces user variability for image acquisition, thus eliminating transducer induced changes that limit CT planning system. Methods: We designed an in‐house integrated US manipulator and platform to relate CT, 3D‐US and linear accelerator coordinate systems. To validate the platform, an agar‐based phantom with measured densities and speed‐of‐sound consistent with tissues surrounding the bladder, was rotated (0–45°) resulting in translations (up to 55mm) relative to the CT and US coordinate systems. After acquiring and integrating CT and US images into the treatment planning system, US‐to‐US and US‐to‐CT images were co‐registered to re‐align the phantom relative to the linear accelerator. Errors in the transformation matrix components were calculate to determine precision of this method under different patient positions. Results: Statistical errors from US‐US registrations for different patient orientations ranged from 0.06–1.66mm for x, y, and z translational components, and 0.00–1.05° for rotational components. Statistical errors from US‐CT registrations were 0.23–1.18mm for the x, y and z translational components, and 0.08–2.52° for the rotational components. Conclusion: Based on our result, this is consistent with currently used techniques for positioning prostate patients if couch re‐positioning is less than a 5 degree rotation. We are now testing this on a dog patient to obtain both inter and intra‐fractional positional errors. Additional design considerations include the future use of ultrasound‐based functionality (photoacoustics, radioacoustics, Doppler) to monitor blood flow and hypoxia and/or in‐vivo dosimetry for applications in other therapeutic techniques, such as hyperthermia, anti‐angiogenesis, and particle therapy.